372 related articles for article (PubMed ID: 16321763)
1. High-dose conformal radiotherapy for supratentorial malignant glioma: a historical comparison.
Tanaka M; Ino Y; Nakagawa K; Tago M; Todo T
Lancet Oncol; 2005 Dec; 6(12):953-60. PubMed ID: 16321763
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy in supratentorial gliomas. A study of 821 cases.
Heesters M; Molenaar W; Go GK
Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic analysis of patients with cerebral glioma treated with radiotherapy].
Wu SX; Deng ML; Li QQ; Zhao C; Lu TX; Li FY; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1561-6. PubMed ID: 15566680
[TBL] [Abstract][Full Text] [Related]
6. [Results of conventional radiotherapy in malignant gliomas:].
Shibamoto Y; Yamashita J; Takahashi M; Yamasaki T; Kikuchi H; Abe M
Gan No Rinsho; 1989 Sep; 35(11):1240-6. PubMed ID: 2554004
[TBL] [Abstract][Full Text] [Related]
7. The role of radiotherapy in the management of spinal cord glioma.
Shirato H; Kamada T; Hida K; Koyanagi I; Iwasaki Y; Miyasaka K; Abe H
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):323-8. PubMed ID: 7673019
[TBL] [Abstract][Full Text] [Related]
8. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in high-grade malignant glioma. A multivariate analysis of 76 cases with postoperative radiotherapy.
Würschmidt F; Bünemann H; Heilmann HP
Strahlenther Onkol; 1995 Jun; 171(6):315-21. PubMed ID: 7597616
[TBL] [Abstract][Full Text] [Related]
10. [Individualized therapy and outcomes of microsurgery, radiotherapy, and chemotherapy for astrocytoma].
Zhou WN; Chen ZP; You C; Mu YG; Sai K; Zhang JY; Zhang XH; Cheng JJ; Xu HC
Ai Zheng; 2004 Nov; 23(11 Suppl):1555-60. PubMed ID: 15566679
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results.
Narayana A; Yamada J; Berry S; Shah P; Hunt M; Gutin PH; Leibel SA
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):892-7. PubMed ID: 16458777
[TBL] [Abstract][Full Text] [Related]
12. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
[TBL] [Abstract][Full Text] [Related]
13. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas.
Levin VA; Prados MR; Wara WM; Davis RL; Gutin PH; Phillips TL; Lamborn K; Wilson CB
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):75-83. PubMed ID: 7721642
[TBL] [Abstract][Full Text] [Related]
14. [Postoperative radiotherapy of supratentorial anaplastic glioma].
Wendt TG; Bacherler B; Baumer K; Rohloff R; Willich N
Strahlenther Onkol; 1986 Jun; 162(6):347-53. PubMed ID: 3738736
[TBL] [Abstract][Full Text] [Related]
15. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
[TBL] [Abstract][Full Text] [Related]
16. Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.
Nelson DF; Curran WJ; Scott C; Nelson JS; Weinstein AS; Ahmad K; Constine LS; Murray K; Powlis WD; Mohiuddin M
Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):193-207. PubMed ID: 8380567
[TBL] [Abstract][Full Text] [Related]
17. Dose-escalated conformal radiotherapy of glioblastomas -- results of a retrospective comparison applying radiation doses of 60 and 70 Gy.
Graf R; Hildebrandt B; Tilly W; Sreenivasa G; Ullrich R; Felix R; Wust P; Maier-Hauff K
Onkologie; 2005 Jun; 28(6-7):325-30. PubMed ID: 15933420
[TBL] [Abstract][Full Text] [Related]
18. Gliomatosis cerebri: treatment results with radiotherapy alone.
Elshaikh MA; Stevens GH; Peereboom DM; Cohen BH; Prayson RA; Lee SY; Barnett GH; Suh JH
Cancer; 2002 Nov; 95(9):2027-31. PubMed ID: 12404298
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy for glioblastoma in the elderly.
Keime-Guibert F; Chinot O; Taillandier L; Cartalat-Carel S; Frenay M; Kantor G; Guillamo JS; Jadaud E; Colin P; Bondiau PY; Meneï P; Loiseau H; Bernier V; Honnorat J; Barrié M; Mokhtari K; Mazeron JJ; Bissery A; Delattre JY;
N Engl J Med; 2007 Apr; 356(15):1527-35. PubMed ID: 17429084
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of surgery and radiation therapy in cases of anaplastic astrocytoma: retrospective analysis of 170 cases.
Nomiya T; Nemoto K; Kumabe T; Takai Y; Yamada S
J Neurosurg; 2007 Apr; 106(4):575-81. PubMed ID: 17432706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
